Rapid resolution of persistent mycophenolate mofetil-induced diarrhoea with a single dose of infliximab.
Bouhbouh
Souad
S
Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
Rookmaaker
Maarten B
MB
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000139:chemically induced* / Q000188:drug therapy; D003967:Diarrhea / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D000069285:Infliximab; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D009173:Mycophenolic Acid